Transaction by Person Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
The interest of Simon Lowth, a Director of the Company, in AstraZeneca ordinary shares, has changed as detailed below.
On 9 August 2011, Mr Lowth exercised an option over 70,138 AstraZeneca ordinary shares at an option price of 1882 pence per share.
Following the exercise, Mr Lowth sold 61,713 of the 70,138 shares so acquired at a price of 2568 pence per share to cover the cost of exercise and associated taxes.
As a result of these transactions, Mr Lowth now has an interest in 261,363 AstraZeneca ordinary shares, which represents approximately 0.02% of the Company's issued ordinary capital.
A C N Kemp
Company Secretary
10 August 2011
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.